Biotechnology
The Biotechnology industry has a total of 592 stocks, with a combined market cap of $1.26 trillion and total revenue of $115.82 billion.
Market Cap
1.26T
Revenue
115.82B
Profits
-36.13B
PE Ratio
n/a
Profit Margin
-31.20%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 129.29B | 1.36% | 1,480,840 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 89.83B | 14.21% | 28,947,265 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 74.55B | 0.94% | 466,001 | 15.53B |
| 4 | ARGX | argenx SE | 51.01B | 0.78% | 511,021 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 40.67B | 0.87% | 2,210,444 | - |
| 6 | ONC | BeOne Medicines AG | 40.30B | 1.24% | 318,333 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 32.73B | 1.28% | 2,691,105 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.13B | 3.63% | 859,782 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.60B | 3.60% | 5,530,231 | 7.53M |
| 10 | BNTX | BioNTech SE | 24.36B | 5.32% | 1,320,366 | 3.03B |
| 11 | INCY | Incyte Corporation | 22.86B | 0.04% | 1,121,728 | 5.82B |
| 12 | INSM | Insmed Incorporated | 21.97B | 0.12% | 2,474,261 | 1.14B |
| 13 | GMAB | Genmab A/S | 21.89B | 2.83% | 2,333,434 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 15.05B | 2.94% | 815,733 | 1.20B |
| 15 | EXEL | Exelixis, Inc. | 14.83B | 1.42% | 2,665,748 | 2.44B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 14.18B | -1.81% | 1,288,280 | 4.60B |
| 17 | SMMT | Summit Therapeutics Inc. | 14.07B | 2.45% | 5,755,325 | - |
| 18 | CORT | Corcept Therapeutics Incorporated | 13.10B | 2.24% | 624,208 | 830.81M |
| 19 | BBIO | BridgeBio Pharma, Inc. | 12.78B | 0.48% | 1,846,372 | 713.07M |
| 20 | HALO | Halozyme Therapeutics, Inc. | 12.53B | 0.53% | 1,845,099 | 1.66B |
| 21 | TECH | Bio-Techne Corporation | 11.36B | 0.01% | 2,182,570 | 1.22B |
| 22 | IBRX | ImmunityBio, Inc. | 11.14B | 6.05% | 18,657,505 | 165.79M |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.90B | -1.08% | 312,959 | 1.28B |
| 24 | PCVX | Vaxcyte, Inc. | 10.62B | 9.78% | 4,380,935 | - |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 10.61B | -0.17% | 2,146,364 | 3.41B |
| 26 | TWST | Twist Bioscience Corporation | 10.02B | 5.08% | 3,540,107 | 431.80M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.82B | 1.32% | 196,947 | 440.48M |
| 28 | KYMR | Kymera Therapeutics, Inc. | 9.35B | 2.84% | 1,305,176 | 105.00M |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 9.30B | 2.73% | 763,092 | 281.99M |
| 30 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.86B | 3.31% | 2,764,864 | 669.50M |
| 31 | AXSM | Axsome Therapeutics, Inc. | 8.82B | -1.02% | 894,483 | 776.57M |
| 32 | CYTK | Cytokinetics, Incorporated | 8.75B | 1.45% | 1,118,074 | 67.67M |
| 33 | CAI | Caris Life Sciences, Inc. | 8.39B | 8.00% | 5,033,907 | 989.61M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 8.01B | 7.25% | 1,116,433 | - |
| 35 | TGTX | TG Therapeutics, Inc. | 7.85B | 3.81% | 1,621,420 | 799.54M |
| 36 | ABVX | ABIVAX Société Anonyme | 7.71B | -1.01% | 885,318 | 5.33M |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.52B | 4.57% | 4,862,316 | 874.09M |
| 38 | PRAX | Praxis Precision Medicines, Inc. | 7.26B | -1.40% | 517,222 | 7.46M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.62B | 9.84% | 16,990,230 | 324.97M |
| 40 | IMVT | Immunovant, Inc. | 6.29B | 0.69% | 1,494,818 | - |
| 41 | KOD | Kodiak Sciences Inc. | 6.26B | 5.95% | 1,735,327 | - |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.25B | 1.27% | 1,411,378 | 239.92M |
| 43 | BLTE | Belite Bio, Inc | 6.22B | 1.29% | 179,300 | - |
| 44 | LGND | Ligand Pharmaceuticals Incorporated | 6.02B | 2.31% | 183,009 | 290.54M |
| 45 | CGON | CG Oncology, Inc. | 5.66B | 0.89% | 516,328 | 6.23M |
| 46 | ERAS | Erasca, Inc. | 5.61B | 3.69% | 7,771,530 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 5.58B | 5.73% | 1,139,627 | 618.07M |
| 48 | MANE | Veradermics, Incorporated | 5.47B | 3.37% | 1,114,026 | - |
| 49 | ORKA | Oruka Therapeutics, Inc. | 5.44B | 6.25% | 1,206,680 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.40B | 3.42% | 1,171,187 | 1.01B |
| 51 | COGT | Cogent Biosciences, Inc. | 5.38B | 3.06% | 2,520,464 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 5.16B | 5.85% | 1,472,030 | 13.39M |
| 53 | SRRK | Scholar Rock Holding Corporation | 5.14B | -0.02% | 1,258,329 | - |
| 54 | DFTX | Definium Therapeutics, Inc. | 4.96B | 7.96% | 2,772,881 | - |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.91B | 0.16% | 1,169,381 | 591.33M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.61B | -0.07% | 738,267 | 1.90M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.24B | -0.43% | 1,062,489 | - |
| 58 | ABCL | AbCellera Biologics Inc. | 4.07B | 4.37% | 4,691,319 | 66.17M |
| 59 | TNGX | Tango Therapeutics, Inc. | 4.01B | 5.49% | 3,098,811 | 53.81M |
| 60 | RLAY | Relay Therapeutics, Inc. | 3.92B | 2.70% | 1,764,485 | 10.35M |
| 61 | TLX | Telix Pharmaceuticals Limited | 3.76B | 1.82% | 311,957 | 890.79M |
| 62 | LEGN | Legend Biotech Corporation | 3.61B | -0.48% | 1,387,470 | 1.27B |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.53B | 0.77% | 1,243,761 | 7.50M |
| 64 | IDYA | IDEAYA Biosciences, Inc. | 3.48B | 0.14% | 698,920 | 234.13M |
| 65 | ACAD | Acadia Pharmaceuticals Inc. | 3.41B | 1.02% | 1,470,244 | 1.14B |
| 66 | PBLS | Parabilis Medicines, Inc. | 3.39B | -2.17% | 1,086,557 | 148.00K |
| 67 | ARQT | Arcutis Biotherapeutics, Inc. | 3.34B | 8.53% | 1,731,706 | 463.98M |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.33B | 2.81% | 4,045,849 | - |
| 69 | CELC | Celcuity Inc. | 3.32B | 0.10% | 1,277,551 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.21B | 1.30% | 481,753 | 606.33M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.11B | 4.18% | 1,340,697 | 3.60M |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.11B | 2.43% | 795,186 | 117.00M |
| 73 | DYN | Dyne Therapeutics, Inc. | 3.11B | 1.65% | 3,564,860 | - |
| 74 | ELVN | Enliven Therapeutics, Inc. | 3.00B | 0.86% | 1,002,658 | - |
| 75 | ZLAB | Zai Lab Limited | 2.81B | 0.73% | 1,024,847 | 449.61M |
| 76 | PGEN | Precigen, Inc. | 2.80B | 2.76% | 3,384,174 | 85.72M |
| 77 | NAMS | NewAmsterdam Pharma Company N.V. | 2.58B | 1.48% | 1,265,986 | 7.12M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.57B | 4.47% | 1,801,584 | 156.04M |
| 79 | MBX | MBX Biosciences, Inc. | 2.56B | -0.02% | 538,783 | - |
| 80 | IRON | Disc Medicine, Inc. | 2.38B | 2.12% | 691,135 | - |
| 81 | SLS | SELLAS Life Sciences Group, Inc. | 2.35B | 3.46% | 4,178,220 | - |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.35B | 2.01% | 992,608 | 158.00K |
| 83 | HRMY | Harmony Biosciences Holdings, Inc. | 2.35B | 1.72% | 487,061 | 959.90M |
| 84 | RXRX | Recursion Pharmaceuticals, Inc. | 2.34B | 10.38% | 35,501,287 | 54.86M |
| 85 | ADMA | ADMA Biologics, Inc. | 2.32B | 0.29% | 2,828,399 | 512.28M |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.32B | 0.63% | 1,525,470 | 36.77M |
| 87 | IMNM | Immunome, Inc. | 2.22B | 1.24% | 998,187 | 4.02M |
| 88 | AUPH | Aurinia Pharmaceuticals Inc. | 2.22B | 2.65% | 849,222 | 311.51M |
| 89 | PHVS | Pharvaris N.V. | 2.18B | -0.06% | 754,990 | - |
| 90 | VERA | Vera Therapeutics, Inc. | 2.15B | 0.50% | 996,574 | - |
| 91 | VRDN | Viridian Therapeutics, Inc. | 2.11B | 1.74% | 1,334,214 | 71.13M |
| 92 | NVAX | Novavax, Inc. | 2.10B | 15.80% | 19,026,371 | 413.80M |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 2.07B | 4.42% | 895,149 | - |
| 94 | VCEL | Vericel Corporation | 2.05B | 0.12% | 506,880 | 306.30M |
| 95 | PVLA | Palvella Therapeutics, Inc. | 2.00B | 5.66% | 173,999 | - |
| 96 | ADRX | ADARx Pharmaceuticals, Inc. | 1.99B | 0.57% | 688,458 | 6.13M |
| 97 | FTRE | Fortrea Holdings Inc. | 1.98B | 2.31% | 931,304 | 2.68B |
| 98 | VIR | Vir Biotechnology, Inc. | 1.98B | 5.22% | 1,965,003 | 303.23M |
| 99 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.93B | 3.19% | 2,306,189 | 208.78M |
| 100 | LKFT | Lakefront Biotherapeutics NV | 1.92B | 0.75% | 212,541 | 1.13B |
| 101 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | -0.34% | 835,681 | 98.34M |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 1.89B | -1.98% | 3,015,043 | 1.97B |
| 103 | TRVI | Trevi Therapeutics, Inc. | 1.88B | 2.85% | 5,029,873 | - |
| 104 | GENB | Generate Biomedicines, Inc. | 1.84B | 2.50% | 903,353 | 26.48M |
| 105 | NTLA | Intellia Therapeutics, Inc. | 1.83B | 3.73% | 8,154,715 | 59.51M |
| 106 | XNCR | Xencor, Inc. | 1.83B | 0.53% | 1,145,230 | 104.97M |
| 107 | ZYME | Zymeworks Inc. | 1.83B | 2.10% | 491,135 | 37.13M |
| 108 | BHVN | Biohaven Ltd. | 1.82B | 1.26% | 1,370,052 | - |
| 109 | GPCR | Structure Therapeutics Inc. | 1.82B | -0.51% | 593,230 | - |
| 110 | MESO | Mesoblast Limited | 1.81B | 3.93% | 178,169 | 120.25M |
| 111 | URGN | UroGen Pharma Ltd. | 1.80B | -0.41% | 3,895,594 | 188.73M |
| 112 | SEPN | Septerna, Inc. | 1.79B | 3.98% | 349,375 | 98.88M |
| 113 | ZBIO | Zenas BioPharma, Inc. | 1.78B | 3.89% | 429,816 | 1.00M |
| 114 | NUVB | Nuvation Bio Inc. | 1.76B | 1.01% | 2,957,047 | 169.90M |
| 115 | ABSI | Absci Corporation | 1.74B | 13.65% | 4,245,312 | 1.56M |
| 116 | OCUL | Ocular Therapeutix, Inc. | 1.66B | 0.40% | 2,630,475 | 52.06M |
| 117 | BRVE | Braveheart Bio, Inc. | 1.63B | 4.87% | 255,238 | - |
| 118 | STOK | Stoke Therapeutics, Inc. | 1.60B | 3.30% | 918,955 | 27.59M |
| 119 | QURE | uniQure N.V. | 1.57B | 0.22% | 1,513,332 | 18.67M |
| 120 | KRSA | Korsana Biosciences, Inc. | 1.54B | 1.22% | 45,915 | - |
| 121 | INVA | Innoviva, Inc. | 1.53B | 1.63% | 507,581 | 440.00M |
| 122 | RARE | Ultragenyx Pharmaceutical Inc. | 1.52B | 1.24% | 2,927,349 | 717.00M |
| 123 | SNDX | Syndax Pharmaceuticals, Inc. | 1.52B | 0.53% | 1,459,036 | 252.25M |
| 124 | IMCR | Immunocore Holdings plc | 1.51B | 1.03% | 452,838 | 430.78M |
| 125 | MAZE | Maze Therapeutics, Inc. | 1.51B | 4.75% | 670,918 | 20.00M |
| 126 | KLRA | Kailera Therapeutics, Inc. | 1.51B | 16.10% | 2,182,264 | - |
| 127 | COAG | Hemab Therapeutics Holdings, Inc. | 1.48B | 2.36% | 619,014 | - |
| 128 | RAPP | Rapport Therapeutics, Inc. | 1.47B | 2.68% | 247,879 | 20.00M |
| 129 | TSHA | Taysha Gene Therapies, Inc. | 1.46B | 1.35% | 5,382,787 | 5.49M |
| 130 | GHRS | GH Research PLC | 1.45B | 3.23% | 146,040 | - |
| 131 | OMER | Omeros Corporation | 1.44B | 3.71% | 793,925 | 38.42M |
| 132 | NKTR | Nektar Therapeutics | 1.41B | 0.91% | 1,174,737 | 54.59M |
| 133 | INBX | Inhibrx Biosciences, Inc. | 1.40B | 2.43% | 86,817 | 1.30M |
| 134 | ANAB | AnaptysBio, Inc. | 1.37B | -0.56% | 495,669 | 106.09M |
| 135 | KARD | Kardigan, Inc. | 1.37B | 3.31% | 740,189 | - |
| 136 | TYRA | Tyra Biosciences, Inc. | 1.37B | -0.15% | 649,438 | - |
| 137 | DRTS | Alpha Tau Medical Ltd. | 1.33B | 2.93% | 368,171 | - |
| 138 | AAPG | Ascentage Pharma Group International | 1.32B | 1.37% | 1,198 | 94.61M |
| 139 | DMRA | Damora Therapeutics, Inc. | 1.30B | 2.53% | 368,607 | - |
| 140 | REPL | Replimune Group, Inc. | 1.26B | 2.91% | 2,016,346 | - |
| 141 | SVRA | Savara Inc. | 1.25B | 1.86% | 1,529,138 | - |
| 142 | ORIC | ORIC Pharmaceuticals, Inc. | 1.24B | -0.33% | 1,086,581 | - |
| 143 | NBTX | Nanobiotix S.A. | 1.21B | 3.41% | 93,496 | 13.15M |
| 144 | LBRX | LB Pharmaceuticals Inc | 1.20B | 7.54% | 642,580 | - |
| 145 | VOR | Vor Biopharma Inc. | 1.18B | 4.03% | 1,102,364 | - |
| 146 | BCAX | Bicara Therapeutics Inc. | 1.16B | 1.39% | 715,972 | - |
| 147 | AVLN | Avalyn Pharma Inc. | 1.14B | 0.16% | 241,836 | - |
| 148 | TRAX | First Tracks Biotherapeutics, Inc. | 1.14B | -0.50% | 855,238 | - |
| 149 | JANX | Janux Therapeutics, Inc. | 1.12B | -0.59% | 1,172,963 | 24.00M |
| 150 | LTGO | Latigo Biotherapeutics, Inc. | 1.06B | 8.18% | 184,215 | - |
| 151 | MNKD | MannKind Corporation | 1.06B | -3.80% | 4,549,635 | 393.63M |
| 152 | MGTX | MeiraGTx Holdings plc | 1.03B | 1.81% | 523,431 | 397.50M |
| 153 | IMTX | Immatics N.V. | 1.02B | 0.81% | 1,371,277 | 47.65M |
| 154 | AKTS | Aktis Oncology, Inc. | 1.01B | 2.31% | 361,042 | 10.06M |
| 155 | ANL | Adlai Nortye Group Ltd. | 1.01B | 0.71% | 300,392 | 18.06M |
| 156 | CGEM | Cullinan Therapeutics, Inc. | 999.43M | 0.45% | 567,509 | - |
| 157 | SPTX | Seaport Therapeutics, Inc. | 971.58M | 1.34% | 171,205 | - |
| 158 | ANRO | Alto Neuroscience, Inc. | 956.33M | 1.41% | 649,427 | - |
| 159 | KURA | Kura Oncology, Inc. | 942.98M | 0.76% | 1,473,708 | 77.23M |
| 160 | ALMS | Alumis Inc. | 926.76M | 2.73% | 1,371,009 | 7.40M |
| 161 | MLTX | MoonLake Immunotherapeutics | 920.85M | 2.27% | 2,010,972 | - |
| 162 | RIGL | Rigel Pharmaceuticals, Inc. | 916.81M | 0.74% | 279,361 | 276.79M |
| 163 | JBIO | Jade Biosciences, Inc. | 915.17M | 1.70% | 735,510 | - |
| 164 | ODTX | Odyssey Therapeutics, Inc. | 910.45M | 4.86% | 325,592 | 99.00K |
| 165 | CRVS | Corvus Pharmaceuticals, Inc. | 884.95M | 3.04% | 1,031,889 | - |
| 166 | GLUE | Monte Rosa Therapeutics, Inc. | 878.73M | -0.19% | 1,201,733 | 28.73M |
| 167 | DNA | Ginkgo Bioworks Holdings, Inc. | 875.42M | 14.64% | 4,519,949 | 132.42M |
| 168 | HELP | Helus Pharma Inc. | 862.11M | 10.07% | 1,664,669 | - |
| 169 | SLBT | SL Science Holding Limited | 861.10M | -0.66% | 25,118 | 3.27M |
| 170 | SANA | Sana Biotechnology, Inc. | 835.22M | - | 2,918,304 | - |
| 171 | ABUS | Arbutus Biopharma Corporation | 834.92M | 0.96% | 3,146,174 | 181.72M |
| 172 | SGP | SpyGlass Pharma, Inc. | 833.52M | 1.22% | 68,252 | - |
| 173 | AVBP | ArriVent BioPharma, Inc. | 824.92M | 0.12% | 1,731,729 | - |
| 174 | ARDX | Ardelyx, Inc. | 817.34M | 0.31% | 2,357,788 | 450.89M |
| 175 | OBX | Obsidian Therapeutics, Inc. | 803.05M | 6.21% | 532,193 | - |
| 176 | GERN | Geron Corporation | 787.03M | 0.41% | 5,639,845 | 204.56M |
| 177 | IMMX | Immix Biopharma, Inc. | 784.26M | 1.83% | 1,109,037 | - |
| 178 | APMD | Apnimed, Inc. | 771.00M | 1.65% | 268,250 | 115.12M |
| 179 | ACHV | Achieve Life Sciences, Inc. | 762.51M | 3.06% | 986,708 | - |
| 180 | ANNX | Annexon, Inc. | 762.11M | 0.50% | 2,385,018 | - |
| 181 | CADL | Candel Therapeutics, Inc. | 760.59M | 2.90% | 718,128 | - |
| 182 | VSTM | Verastem, Inc. | 758.92M | 3.33% | 2,970,338 | 87.53M |
| 183 | IVA | Inventiva S.A. | 756.65M | -4.82% | 2,788,754 | 2.81M |
| 184 | LXRX | Lexicon Pharmaceuticals, Inc. | 747.53M | -4.55% | 2,067,692 | 41.47M |
| 185 | GYRE | Gyre Therapeutics, Inc. | 746.48M | 4.14% | 76,632 | 109.82M |
| 186 | ATTO | Attovia Therapeutics, Inc. | 740.01M | -0.61% | 194,180 | 1.80M |
| 187 | SLDB | Solid Biosciences Inc. | 736.64M | 0.73% | 726,721 | - |
| 188 | FDMT | 4D Molecular Therapeutics, Inc. | 736.41M | 4.96% | 867,987 | 92.01M |
| 189 | AVTX | Avalo Therapeutics, Inc. | 732.05M | 1.64% | 648,577 | 59.00K |
| 190 | DSGN | Design Therapeutics, Inc. | 729.08M | 1.39% | 356,593 | - |
| 191 | PRME | Prime Medicine, Inc. | 709.84M | 11.45% | 8,066,135 | 4.07M |
| 192 | OABI | OmniAb, Inc. | 696.42M | 2.79% | 1,039,170 | 38.46M |
| 193 | PHAR | Pharming Group N.V. | 694.55M | 2.73% | 3,331 | 366.48M |
| 194 | NVCT | Nuvectis Pharma, Inc. | 688.12M | 4.92% | 152,958 | - |
| 195 | OLMA | Olema Pharmaceuticals, Inc. | 684.23M | - | 758,248 | - |
| 196 | WVE | Wave Life Sciences, Inc. | 681.79M | -0.29% | 1,655,983 | 65.37M |
| 197 | MDXG | MiMedx Group, Inc. | 680.70M | 1.08% | 391,112 | 355.17M |
| 198 | AURA | Aura Biosciences, Inc. | 678.23M | 0.46% | 962,556 | - |
| 199 | ZVRA | Zevra Therapeutics, Inc. | 676.38M | 3.55% | 730,642 | 136.07M |
| 200 | FTH | Faeth Therapeutics, Inc. | 672.63M | 1.64% | 197,135 | - |
| 201 | CBIO | Crescent Biopharma, Inc. | 638.16M | 5.59% | 347,123 | 11.88M |
| 202 | SGMT | Sagimet Biosciences Inc. | 633.21M | 0.11% | 763,530 | - |
| 203 | CLYM | Climb Bio, Inc. | 631.80M | 1.29% | 638,138 | - |
| 204 | STTK | Shattuck Labs, Inc. | 599.17M | 5.48% | 1,049,337 | 1.00M |
| 205 | SLN | Silence Therapeutics plc | 593.66M | 3.57% | 844,344 | 615.00K |
| 206 | PHAT | Phathom Pharmaceuticals, Inc. | 575.87M | 1.68% | 928,338 | 239.66M |
| 207 | CRMD | CorMedix Inc. | 575.23M | 0.82% | 1,257,046 | 462.25M |
| 208 | ETRA | Electra Therapeutics, Inc. | 567.41M | -1.09% | 778,360 | - |
| 209 | ACRS | Aclaris Therapeutics, Inc. | 563.77M | 1.06% | 5,060,057 | 8.22M |
| 210 | CTMX | CytomX Therapeutics, Inc. | 560.00M | 4.05% | 3,040,160 | 18.30M |
| 211 | DBVT | DBV Technologies S.A. | 555.98M | 2.62% | 324,016 | 5.04M |
| 212 | BLSM | BlossomHill Therapeutics, Inc. | 555.60M | 3.55% | 131,828 | - |
| 213 | VALN | Valneva SE | 537.87M | 1.58% | 5,605 | 163.30M |
| 214 | DRUG | Bright Minds Biosciences Inc. | 533.01M | 3.94% | 98,401 | - |
| 215 | RGNX | REGENXBIO Inc. | 532.73M | -0.25% | 859,286 | 174.48M |
| 216 | PBYI | Puma Biotechnology, Inc. | 531.17M | 3.21% | 303,060 | 231.24M |
| 217 | MNPR | Monopar Therapeutics Inc. | 529.99M | -5.98% | 135,845 | - |
| 218 | NGNE | Neurogene Inc. | 528.30M | -0.38% | 465,832 | 925.00K |
| 219 | PROK | ProKidney Corp. | 526.04M | 4.82% | 1,385,948 | 818.00K |
| 220 | OCS | Oculis Holding AG | 514.85M | -3.70% | 162,060 | 1.45M |
| 221 | RZLT | Rezolute, Inc. | 510.85M | 4.96% | 1,873,613 | - |
| 222 | ALT | Altimmune, Inc. | 507.69M | 0.38% | 2,677,674 | 31.00K |
| 223 | ALLO | Allogene Therapeutics, Inc. | 504.42M | 4.29% | 10,605,411 | 4.64M |
| 224 | CTNM | Contineum Therapeutics, Inc. | 503.37M | 1.52% | 885,578 | - |
| 225 | ARVN | Arvinas, Inc. | 499.55M | 1.73% | 559,960 | 316.70M |
| 226 | EPRX | Eupraxia Pharmaceuticals Inc. | 491.01M | -1.45% | 1,051,830 | - |
| 227 | MPLT | MapLight Therapeutics, Inc. | 490.73M | -3.50% | 495,282 | - |
| 228 | AUTL | Autolus Therapeutics plc | 481.75M | 2.26% | 1,476,329 | 117.39M |
| 229 | OVID | Ovid Therapeutics Inc. | 480.43M | 5.13% | 1,406,675 | 1.58M |
| 230 | ASMB | Assembly Biosciences, Inc. | 479.08M | 3.11% | 170,465 | 74.85M |
| 231 | YDES | YD Bio Limited | 476.69M | 16.23% | 207,769 | 1.24M |
| 232 | ENTX | Entera Bio Ltd. | 460.56M | 6.40% | 1,584,050 | 42.00K |
| 233 | TECX | Tectonic Therapeutic, Inc. | 456.09M | 2.55% | 110,712 | - |
| 234 | CAPR | Capricor Therapeutics, Inc. | 455.23M | -2.25% | 1,697,662 | 11.13M |
| 235 | PRTA | Prothena Corporation plc | 453.82M | 2.67% | 931,618 | 54.53M |
| 236 | DMAC | DiaMedica Therapeutics Inc. | 449.20M | 4.00% | 170,151 | - |
| 237 | AGMB | AgomAb Therapeutics NV | 447.17M | -1.52% | 102,314 | - |
| 238 | EDIT | Editas Medicine, Inc. | 445.38M | 2.11% | 3,086,658 | 47.01M |
| 239 | SPRY | ARS Pharmaceuticals, Inc. | 420.66M | -7.24% | 1,258,394 | 116.93M |
| 240 | AVIR | Atea Pharmaceuticals, Inc. | 413.05M | -0.19% | 157,965 | - |
| 241 | EIKN | Eikon Therapeutics, Inc. | 404.61M | -0.40% | 288,688 | - |
| 242 | SCTX | Scribe Therapeutics Inc. | 400.78M | 10.09% | 396,955 | 33.30M |
| 243 | PRLD | Prelude Therapeutics Incorporated | 400.65M | 0.26% | 341,643 | 22.42M |
| 244 | GALT | Galectin Therapeutics Inc. | 397.35M | 8.24% | 156,405 | - |
| 245 | KYTX | Kyverna Therapeutics, Inc. | 395.18M | 3.40% | 876,391 | - |
| 246 | ARCT | Arcturus Therapeutics Holdings Inc. | 390.53M | 6.76% | 675,586 | 29.37M |
| 247 | CCCC | C4 Therapeutics, Inc. | 388.76M | 10.88% | 2,506,710 | 35.04M |
| 248 | VTVT | vTv Therapeutics Inc. | 387.41M | 3.66% | 12,835 | 36.84M |
| 249 | IRD | Opus Genetics, Inc. | 386.86M | 4.26% | 1,257,290 | 9.86M |
| 250 | ZURA | Zura Bio Limited | 383.32M | -3.15% | 1,707,943 | - |
| 251 | TRXB | TRex Bio, Inc. | 376.91M | - | 1,258,340 | - |
| 252 | FENC | Fennec Pharmaceuticals Inc. | 375.57M | 0.75% | 93,462 | 59.22M |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 364.07M | 3.31% | 181,970 | 65.26M |
| 254 | RLMD | Relmada Therapeutics, Inc. | 361.61M | 6.94% | 1,730,497 | - |
| 255 | IKT | Inhibikase Therapeutics, Inc. | 358.69M | 3.14% | 435,029 | 1.00 |
| 256 | OBIO | Orchestra BioMed Holdings, Inc. | 357.63M | 3.84% | 229,312 | 31.98M |
| 257 | TTRX | Turn Therapeutics Inc. | 357.46M | 5.36% | 109,786 | - |
| 258 | SRZN | Surrozen, Inc. | 348.96M | 6.15% | 781,384 | 11.51M |
| 259 | AGEN | Agenus Inc. | 345.31M | 1.72% | 710,240 | 132.69M |
| 260 | ARTV | Artiva Biotherapeutics, Inc. | 339.30M | 2.06% | 275,927 | 251.00K |
| 261 | INDP | Indaptus Therapeutics, Inc. | 334.44M | 5.91% | 467,591 | - |
| 262 | CABA | Cabaletta Bio, Inc. | 327.22M | -1.03% | 2,592,696 | - |
| 263 | OCGN | Ocugen, Inc. | 324.02M | -2.24% | 13,335,901 | 4.58M |
| 264 | BNTC | Benitec Biopharma Inc. | 309.41M | 1.37% | 73,143 | - |
| 265 | EYPT | EyePoint, Inc. | 293.12M | -1.73% | 1,938,645 | 2.79M |
| 266 | XFOR | X4 Pharmaceuticals, Inc. | 288.52M | 4.30% | 541,198 | 15.85M |
| 267 | FULC | Fulcrum Therapeutics, Inc. | 287.64M | 0.53% | 1,798,880 | 80.00M |
| 268 | NAUT | Nautilus Biotechnology, Inc. | 286.32M | 23.63% | 19,575,734 | 190.00K |
| 269 | ABEO | Abeona Therapeutics Inc. | 282.49M | -0.40% | 1,284,749 | 25.52M |
| 270 | RCKT | Rocket Pharmaceuticals, Inc. | 281.02M | -2.66% | 3,371,743 | - |
| 271 | CUVL | Clinuvel Pharmaceuticals Limited | 279.41M | -0.18% | 1,622 | 65.05M |
| 272 | LRMR | Larimar Therapeutics, Inc. | 278.70M | -1.11% | 868,878 | - |
| 273 | VNDA | Vanda Pharmaceuticals Inc. | 276.31M | 0.88% | 640,028 | 215.72M |
| 274 | BCYC | Bicycle Therapeutics plc | 272.27M | 2.10% | 300,616 | 61.21M |
| 275 | SABS | SAB Biotherapeutics, Inc. | 271.14M | 3.11% | 659,608 | 114.70K |
| 276 | PALI | Palisade Bio, Inc. | 268.38M | 6.21% | 1,841,006 | 500.00K |
| 277 | IPSC | Century Therapeutics, Inc. | 266.18M | 0.68% | 817,029 | 109.16M |
| 278 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 265.38M | -3.22% | 471,951 | - |
| 279 | LXEO | Lexeo Therapeutics, Inc. | 265.00M | 0.62% | 961,282 | - |
| 280 | FATE | Fate Therapeutics, Inc. | 261.21M | 2.35% | 773,152 | 6.49M |
| 281 | VOGX | Vogenx, Inc. | 260.86M | 0.40% | 77,188 | - |
| 282 | UPB | Upstream Bio, Inc. | 257.42M | 3.30% | 1,187,808 | 3.16M |
| 283 | IMRX | Immuneering Corporation | 254.91M | 5.35% | 709,461 | - |
| 284 | VCRE | Vicore Pharma Holding AB (publ) | 253.39M | 2.04% | 30,924 | 412.09K |
| 285 | LCTX | Lineage Cell Therapeutics, Inc. | 251.39M | -3.50% | 1,158,177 | 13.08M |
| 286 | ZNTL | Zentalis Pharmaceuticals, Inc. | 249.93M | 5.18% | 612,358 | 26.87M |
| 287 | ACIU | AC Immune SA | 248.57M | -1.96% | 271,324 | 21.67M |
| 288 | QTTB | Q32 Bio Inc. | 248.28M | 3.09% | 854,797 | 53.74M |
| 289 | GLSI | Greenwich LifeSciences, Inc. | 242.63M | 9.18% | 119,878 | - |
| 290 | PYXS | Pyxis Oncology, Inc. | 242.50M | 2.01% | 950,364 | 11.04M |
| 291 | MGNX | MacroGenics, Inc. | 238.24M | 5.35% | 418,432 | 175.14M |
| 292 | KROS | Keros Therapeutics, Inc. | 236.93M | 2.66% | 194,391 | 15.01M |
| 293 | STRO | Sutro Biopharma, Inc. | 236.61M | -6.85% | 256,223 | 45.70M |
| 294 | CAMP | Camp4 Therapeutics Corporation | 236.58M | 1.89% | 72,145 | 4.22M |
| 295 | IFRX | InflaRx N.V. | 235.79M | 4.58% | 740,708 | -11.54K |
| 296 | SLGL | Sol-Gel Technologies Ltd. | 234.97M | 2.03% | 31,468 | 1.80M |
| 297 | ALEC | Alector, Inc. | 232.25M | 2.97% | 3,118,490 | 13.86M |
| 298 | PRQR | ProQR Therapeutics N.V. | 230.03M | 3.82% | 676,079 | 21.05M |
| 299 | EVMN | Evommune, Inc. | 226.83M | -2.50% | 557,955 | 10.00M |
| 300 | PLX | Protalix BioTherapeutics, Inc. | 223.99M | 2.96% | 1,198,885 | 80.62M |
| 301 | SION | Sionna Therapeutics, Inc. | 221.54M | - | 633,501 | - |
| 302 | RNAC | Cartesian Therapeutics, Inc. | 213.45M | 3.45% | 114,544 | 1.48M |
| 303 | LYEL | Lyell Immunopharma, Inc. | 213.44M | -0.91% | 106,807 | 27.00K |
| 304 | IVVD | Invivyd, Inc. | 212.58M | 2.97% | 2,767,048 | 58.37M |
| 305 | TRDA | Entrada Therapeutics, Inc. | 204.44M | 2.53% | 209,363 | 4.69M |
| 306 | CGEN | Compugen Ltd. | 201.76M | 0.47% | 123,361 | 74.00M |
| 307 | ELDN | Eledon Pharmaceuticals, Inc. | 201.73M | 2.48% | 817,901 | - |
| 308 | CUE | Cue Biopharma, Inc. | 200.93M | 23.87% | 394,377 | 37.66M |
| 309 | WHWK | Whitehawk Therapeutics, Inc. | 200.67M | 1.44% | 320,255 | 7.15M |
| 310 | ACOG | Alpha Cognition Inc. | 196.87M | - | 20,332 | 15.26M |
| 311 | NGEN | NervGen Pharma Corp. | 186.01M | -1.14% | 293,025 | - |
| 312 | DTIL | Precision BioSciences, Inc. | 185.48M | 4.51% | 263,689 | 45.06M |
| 313 | ADAG | Adagene Inc. | 185.32M | -0.72% | 1,649,349 | 9.29M |
| 314 | YARW | Yarrow Bioscience, Inc. | 183.39M | -0.81% | 162,192 | - |
| 315 | PEPG | PepGen Inc. | 181.46M | 10.08% | 603,802 | - |
| 316 | ORMP | Oramed Pharmaceuticals Inc. | 180.12M | 3.10% | 193,499 | 2.00M |
| 317 | CMPX | Compass Therapeutics, Inc. | 178.83M | 0.98% | 3,670,593 | 850.00K |
| 318 | VRXA | Veraxa Biotech AG | 178.17M | 15.60% | 1,862,521 | 29.54K |
| 319 | ALXO | ALX Oncology Holdings Inc. | 172.85M | 5.93% | 1,224,924 | - |
| 320 | CNTN | Canton Strategic Holdings, Inc. | 168.13M | 1.44% | 726,124 | 1.50M |
| 321 | ANTX | AN2 Therapeutics, Inc. | 166.04M | -5.98% | 442,133 | - |
| 322 | CHRS | Coherus Oncology, Inc. | 165.32M | - | 1,697,092 | 50.94M |
| 323 | TARA | Protara Therapeutics, Inc. | 162.81M | 3.96% | 1,037,307 | - |
| 324 | MDWD | MediWound Ltd. | 161.89M | 0.97% | 92,645 | 11.86M |
| 325 | NBP | NovaBridge Biosciences | 161.82M | 1.82% | 295,923 | - |
| 326 | NKTX | Nkarta, Inc. | 161.16M | 1.35% | 904,869 | - |
| 327 | MSLE | Satellos Bioscience Inc. | 159.25M | 1.90% | 59,900 | - |
| 328 | MENS | Jyong Biotech Ltd. | 155.89M | - | 36,708 | - |
| 329 | ABOS | Acumen Pharmaceuticals, Inc. | 154.76M | 1.90% | 357,535 | - |
| 330 | CDXS | Codexis, Inc. | 154.40M | 3.68% | 555,425 | 77.68M |
| 331 | TLSA | Tiziana Life Sciences Ltd | 153.88M | 5.31% | 2,423,975 | - |
| 332 | NERV | Minerva Neurosciences, Inc. | 151.84M | -1.24% | 192,461 | - |
| 333 | VYGR | Voyager Therapeutics, Inc. | 150.96M | 3.38% | 694,348 | 34.46M |
| 334 | KRRO | Korro Bio, Inc. | 149.61M | -3.97% | 133,510 | 2.38M |
| 335 | MOLN | Molecular Partners AG | 148.00M | 1.05% | 5,747 | 856.30K |
| 336 | OTLK | Outlook Therapeutics, Inc. | 145.80M | 6.19% | 3,685,011 | -1.16M |
| 337 | RNA | Atrium Therapeutics, Inc. | 143.69M | 1.69% | 208,344 | 35.84M |
| 338 | AVXL | Anavex Life Sciences Corp. | 138.12M | -3.25% | 1,286,261 | - |
| 339 | IPHA | Innate Pharma S.A. | 136.60M | 9.46% | 46,875 | 11.21M |
| 340 | ARMP | Armata Pharmaceuticals, Inc. | 134.97M | -5.96% | 100,581 | 5.54M |
| 341 | TNYA | Tenaya Therapeutics, Inc. | 130.12M | 6.63% | 4,304,193 | 1.34M |
| 342 | SPRB | Spruce Biosciences, Inc. | 126.60M | -3.27% | 83,584 | 697.00K |
| 343 | TNXP | Tonix Pharmaceuticals Holding Corp. | 125.20M | 0.27% | 963,546 | 29.10M |
| 344 | HURA | TuHURA Biosciences, Inc. | 124.90M | 1.55% | 148,973 | - |
| 345 | NRXP | NRx Pharmaceuticals, Inc. | 123.30M | -1.38% | 289,297 | 3.39M |
| 346 | KZIA | Kazia Therapeutics Limited | 122.37M | 1.25% | 123,436 | 1.27M |
| 347 | SEER | Seer, Inc. | 121.26M | 0.92% | 204,187 | 14.22M |
| 348 | INO | Inovio Pharmaceuticals, Inc. | 118.91M | 5.50% | 2,892,840 | 65.34K |
| 349 | FHTX | Foghorn Therapeutics Inc. | 118.77M | 0.50% | 646,747 | 36.74M |
| 350 | CBUS | Cibus, Inc. | 118.46M | -2.52% | 44,219 | 4.35M |
| 351 | COYA | Coya Therapeutics, Inc. | 116.12M | -0.80% | 151,816 | 8.02M |
| 352 | ENGN | enGene Therapeutics Inc. | 115.94M | -2.81% | 358,849 | - |
| 353 | PMVP | PMV Pharmaceuticals, Inc. | 114.78M | 2.01% | 890,447 | - |
| 354 | GNLX | Genelux Corporation | 114.72M | 2.40% | 154,649 | 8.00K |
| 355 | LENZ | LENZ Therapeutics, Inc. | 114.53M | 3.26% | 625,763 | 21.48M |
| 356 | UNCY | Unicycive Therapeutics, Inc. | 114.49M | 0.98% | 551,362 | - |
| 357 | VANI | Vivani Medical, Inc. | 112.75M | 1.63% | 101,927 | - |
| 358 | HUMA | Humacyte, Inc. | 112.59M | -9.35% | 8,597,894 | 2.12M |
| 359 | IMUX | Immunic, Inc. | 111.75M | 8.33% | 512,176 | - |
| 360 | RANI | Rani Therapeutics Holdings, Inc. | 111.38M | 0.88% | 235,937 | 4.88M |
| 361 | CNXU | Conexeu Sciences Inc. | 109.72M | 12.75% | 427,952 | - |
| 362 | MIST | Milestone Pharmaceuticals Inc. | 107.80M | 7.43% | 1,226,324 | 2.34M |
| 363 | TENX | Tenax Therapeutics, Inc. | 107.12M | 0.54% | 2,345,206 | - |
| 364 | TVGN | Tevogen Inc. | 106.69M | -3.97% | 2,739 | - |
| 365 | BDTX | Black Diamond Therapeutics, Inc. | 105.14M | 1.10% | 448,785 | 70.00M |
| 366 | AARD | Aardvark Therapeutics, Inc. | 104.17M | 1.06% | 140,863 | - |
| 367 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 104.06M | 2.09% | 872,660 | - |
| 368 | PYPD | PolyPid Ltd. | 102.98M | 3.47% | 60,179 | - |
| 369 | BMEA | Biomea Fusion, Inc. | 102.93M | 3.65% | 1,170,623 | - |
| 370 | ANIX | Anixa Biosciences, Inc. | 100.82M | -0.34% | 217,779 | - |
| 371 | PDSB | PDS Biotechnology Corporation | 100.01M | 35.29% | 16,061,955 | - |
| 372 | PLYX | Polaryx Therapeutics, Inc. | 99.69M | - | - | - |
| 373 | OKUR | OnKure Therapeutics, Inc. | 97.60M | 4.78% | 774,538 | - |
| 374 | ATRA | Atara Biotherapeutics, Inc. | 95.16M | 2.71% | 22,147 | 6.19M |
| 375 | CLLS | Cellectis S.A. | 91.82M | 0.80% | 75,757 | 63.82M |
| 376 | RLYB | Rallybio Corporation | 90.38M | 0.18% | 6,942 | 646.00K |
| 377 | EQ | Equillium, Inc. | 89.41M | -2.08% | 520,199 | 4.39M |
| 378 | NMRA | Neumora Therapeutics, Inc. | 89.38M | -0.85% | 789,405 | - |
| 379 | ICCC | ImmuCell Corporation | 89.01M | 0.51% | 1,855 | 30.68M |
| 380 | RTSN | Retension Pharmaceuticals, Inc. | 87.73M | -12.25% | 788,905 | - |
| 381 | NRXS | NeurAxis, Inc. | 87.03M | 2.36% | 56,734 | 5.32M |
| 382 | PMN | ProMIS Neurosciences, Inc. | 86.18M | 5.03% | 18,837 | - |
| 383 | CRDF | Cardiff Oncology, Inc. | 84.02M | 1.89% | 298,115 | 508.00K |
| 384 | CGTX | Cognition Therapeutics, Inc. | 83.39M | -2.04% | 315,626 | - |
| 385 | TELO | Telomir Pharmaceuticals, Inc. | 82.45M | -2.61% | 64,613 | - |
| 386 | ACRV | Acrivon Therapeutics, Inc. | 81.85M | 2.14% | 192,026 | - |
| 387 | NTRB | Nutriband Inc. | 80.84M | 9.92% | 45,134 | 1.62M |
| 388 | PTHS | Pelthos Therapeutics Inc. | 78.48M | - | 45,019 | 43.30M |
| 389 | HRTX | Heron Therapeutics, Inc. | 77.10M | 13.37% | 3,496,907 | 151.18M |
| 390 | MNOV | MediciNova, Inc. | 74.82M | -1.30% | 69,863 | 920.48K |
| 391 | OSTX | OS Therapies Incorporated | 74.72M | - | 422,126 | - |
| 392 | OKYO | OKYO Pharma Limited | 74.52M | 2.16% | 115,549 | - |
| 393 | MAIA | MAIA Biotechnology, Inc. | 74.21M | 6.09% | 375,298 | - |
| 394 | GANX | Gain Therapeutics, Inc. | 71.58M | 1.55% | 328,560 | - |
| 395 | FBIO | Fortress Biotech, Inc. | 71.20M | 2.15% | 186,043 | 68.47M |
| 396 | CING | Cingulate Inc. | 71.11M | 0.20% | 27,812 | - |
| 397 | ONCY | Oncolytics Biotech Inc. | 71.02M | 2.31% | 1,461,368 | - |
| 398 | VRCA | Verrica Pharmaceuticals Inc. | 70.60M | -1.67% | 46,526 | 30.32M |
| 399 | HYFT | MindWalk Holdings Corp. | 70.43M | 4.55% | 238,910 | 11.57M |
| 400 | SPRO | Spero Therapeutics, Inc. | 69.88M | 5.26% | 438,794 | 47.00M |
| 401 | XBIT | XBiotech Inc. | 69.82M | 4.09% | 88,031 | - |
| 402 | NTHI | NeOnc Technologies Holdings, Inc. | 69.10M | 9.88% | 165,846 | 39.99K |
| 403 | RNTX | Rein Therapeutics Inc. | 68.50M | 3.21% | 307,495 | - |
| 404 | CSBR | Champions Oncology, Inc. | 67.37M | -2.81% | 1,866 | 60.66M |
| 405 | PLRX | Pliant Therapeutics, Inc. | 63.16M | 2.00% | 288,517 | - |
| 406 | ALPS | Alps Group Inc | 61.57M | 0.19% | 55,376 | 3.74M |
| 407 | ACET | Adicet Bio, Inc. | 60.39M | -2.26% | 189,826 | - |
| 408 | XLO | Xilio Therapeutics, Inc. | 59.55M | 0.44% | 5,529 | 64.09M |
| 409 | GUTS | Fractyl Health, Inc. | 58.63M | 4.49% | 198,300 | 3.00K |
| 410 | RNXT | RenovoRx, Inc. | 57.77M | -3.76% | 798,787 | 1.98M |
| 411 | BOLD | Boundless Bio, Inc. | 57.55M | -1.94% | 166,793 | - |
| 412 | GOSS | Gossamer Bio, Inc. | 56.94M | -5.77% | 290,997 | 53.29M |
| 413 | ATHE | Alterity Therapeutics Limited | 56.76M | 1.47% | 22,656 | 2.50M |
| 414 | KLRS | Kalaris Therapeutics, Inc. | 56.18M | -5.60% | 104,424 | - |
| 415 | IBIO | iBio, Inc. | 56.01M | -5.33% | 1,646,550 | 100.00K |
| 416 | MREO | Mereo BioPharma Group plc | 55.88M | -6.74% | 1,222,321 | 500.00K |
| 417 | ELOX | Eloxx Pharmaceuticals, Inc. | 55.46M | -9.49% | 31,307 | - |
| 418 | ALDX | Aldeyra Therapeutics, Inc. | 55.28M | -3.31% | 698,974 | - |
| 419 | CLNN | Clene Inc. | 54.87M | -0.52% | 48,131 | 197.00K |
| 420 | CNTB | Connect Biopharma Holdings Limited | 54.79M | -1.21% | 1,054,537 | 2.95M |
| 421 | INKT | MiNK Therapeutics, Inc. | 54.70M | -2.55% | 16,875 | - |
| 422 | LONA | LeonaBio, Inc. | 54.17M | - | 66,683 | - |
| 423 | HYPD | Hyperion DeFi, Inc. | 52.83M | 1.04% | 217,183 | 1.40M |
| 424 | INMB | INmune Bio Inc. | 52.45M | 3.28% | 91,630 | 50.00K |
| 425 | ANVS | Annovis Bio, Inc. | 51.55M | 3.42% | 521,890 | - |
| 426 | SER | Serina Therapeutics, Inc. | 50.80M | -0.50% | 22,349 | 130.00K |
| 427 | CELU | Celularity Inc. | 50.62M | 6.85% | 53,070 | 18.97M |
| 428 | ELTX | Elicio Therapeutics, Inc. | 49.67M | 4.42% | 306,157 | - |
| 429 | CRBU | Caribou Biosciences, Inc. | 49.34M | -4.36% | 9,710,262 | 10.04M |
| 430 | EXOZ | eXoZymes, Inc. | 48.73M | -0.38% | - | -700.00 |
| 431 | CRVO | CervoMed Inc. | 48.68M | -1.83% | 237,310 | 331.30K |
| 432 | IMA | ImageneBio, Inc. | 48.13M | -0.47% | 8,119 | 800.00K |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 47.61M | 7.65% | 704,607 | 21.00M |
| 434 | DWTX | Dogwood Therapeutics, Inc. | 47.59M | -0.71% | 66,061 | - |
| 435 | EDSA | Edesa Biotech, Inc. | 47.43M | -4.10% | 35,399 | - |
| 436 | APLM | Apollomics, Inc. | 47.22M | -1.29% | 8,792 | 8.84M |
| 437 | BSEM | BioStem Technologies, Inc. | 45.90M | -6.44% | 66,045 | 34.59M |
| 438 | TIL | Instil Bio, Inc. | 45.71M | 2.74% | 37,620 | - |
| 439 | GRCE | Grace Therapeutics, Inc. | 43.75M | 1.96% | 37,790 | - |
| 440 | VERU | Veru Inc. | 41.94M | 1.65% | 128,881 | 16.89M |
| 441 | FLNA | Filana Therapeutics, Inc. | 39.46M | 0.39% | 408,492 | - |
| 442 | LITS | Lite Strategy, Inc. | 38.62M | 4.10% | 539,928 | - |
| 443 | MGX | Metagenomi Therapeutics, Inc. | 37.78M | 0.68% | 147,136 | 13.56M |
| 444 | IBO | Impact BioMedical Inc. | 36.31M | 3.41% | 4,028 | 35.00K |
| 445 | GRDX | GridAI Technologies Corp. | 35.19M | 3.54% | 100,635 | - |
| 446 | ATNM | Actinium Pharmaceuticals, Inc. | 34.59M | 1.85% | 105,763 | 35.09M |
| 447 | BCTX | BriaCell Therapeutics Corp. | 34.21M | -0.26% | 23,238 | - |
| 448 | CVM | CEL-SCI Corporation | 34.12M | -0.51% | 255,449 | - |
| 449 | ALGS | Aligos Therapeutics, Inc. | 33.35M | 0.56% | 8,909 | 31.52M |
| 450 | NNVC | NanoViricides, Inc. | 33.18M | -0.76% | 169,627 | - |
| 451 | NXTC | NextCure, Inc. | 32.87M | 5.90% | 85,593 | - |
| 452 | QNCX | Quince Therapeutics, Inc. | 32.27M | 8.07% | 138,465 | - |
| 453 | RNAZ | TransCode Therapeutics, Inc. | 31.49M | 8.77% | 84,067 | - |
| 454 | IGC | IGC Pharma, Inc. | 28.94M | -1.76% | 232,248 | 1.11M |
| 455 | CNTX | Context Therapeutics Inc. | 27.95M | 1.74% | 588,665 | - |
| 456 | MCRB | Seres Therapeutics, Inc. | 27.22M | 3.04% | 79,407 | 1.88M |
| 457 | IMMP | Immutep Limited | 26.74M | -5.47% | 23,307 | 13.79M |
| 458 | ABVC | ABVC BioPharma, Inc. | 25.92M | 2.04% | 41,465 | 797.92K |
| 459 | EVAX | Evaxion A/S | 25.60M | 0.66% | 27,831 | 7.49M |
| 460 | BYSI | BeyondSpring Inc. | 24.90M | -0.56% | 58,926 | 1.88M |
| 461 | KYNB | Kyntra Bio, Inc. | 24.74M | 2.52% | 6,564 | 4.62M |
| 462 | ATOS | Atossa Therapeutics, Inc. | 24.35M | 0.83% | 265,554 | - |
| 463 | ATYR | aTyr Pharma, Inc. | 24.15M | -3.56% | 1,000,612 | 190.00K |
| 464 | QNTM | Quantum BioPharma Ltd. | 23.78M | -5.47% | 129,480 | - |
| 465 | PLRZ | Polyrizon Ltd. | 21.83M | 1.33% | 40,051 | - |
| 466 | QNRX | Quoin Pharmaceuticals, Ltd. | 21.62M | -1.10% | 42,459 | - |
| 467 | COCP | Cocrystal Pharma, Inc. | 20.61M | - | 3,961 | 330.00K |
| 468 | AKTX | Akari Therapeutics, Plc | 20.04M | 7.87% | 76,445 | - |
| 469 | ICU | SeaStar Medical Holding Corporation | 18.99M | 3.44% | 104,912 | 1.71M |
| 470 | JSPR | Jasper Therapeutics, Inc. | 18.97M | 1.82% | 261,893 | - |
| 471 | PBM | Psyence Biomedical Ltd. | 18.96M | -2.93% | 23,963 | - |
| 472 | NEUP | Neuphoria Therapeutics Inc. | 18.18M | 0.30% | 2,516 | 1.17M |
| 473 | ESLA | Estrella Immunopharma, Inc. | 17.83M | -1.80% | 19,845,670 | - |
| 474 | NCEL | NewcelX Ltd. | 17.59M | -2.09% | 1,326 | - |
| 475 | MRKR | Marker Therapeutics, Inc. | 16.20M | 2.27% | 91,219 | 3.55M |
| 476 | DYAI | Dyadic International, Inc. | 16.18M | -0.07% | 11,973 | 3.80M |
| 477 | KPRX | Kiora Pharmaceuticals, Inc. | 16.16M | 0.40% | 4,488 | 20.00K |
| 478 | TCRX | TScan Therapeutics, Inc. | 16.13M | 4.29% | 873,346 | 7.11M |
| 479 | ALLR | Allarity Therapeutics, Inc. | 15.75M | 0.82% | 97,036 | 345.00K |
| 480 | BCDA | BioCardia, Inc. | 15.74M | -1.89% | 101,925 | 3.00K |
| 481 | KTTA | Pasithea Therapeutics Corp. | 15.62M | 6.03% | 60,577 | - |
| 482 | PTN | Palatin Technologies, Inc. | 15.51M | -4.55% | 31,409 | 13.19M |
| 483 | RADX | Radiopharm Theranostics Limited | 15.13M | 1.80% | 65,761 | 8.90M |
| 484 | HIND | Vyome Holdings, Inc. | 14.67M | 2.96% | - | 129.73K |
| 485 | ACTU | Actuate Therapeutics, Inc. | 14.65M | -10.13% | 301,185 | - |
| 486 | CNSY | Cerenome, Inc. | 14.65M | 7.82% | 151,412 | 4.20M |
| 487 | LPCN | Lipocine Inc. | 14.18M | -10.88% | 1,056,683 | 1.57M |
| 488 | AEON | AEON Biopharma, Inc. | 13.77M | -10.97% | 1,627,967 | - |
| 489 | TVRD | Tvardi Therapeutics, Inc. | 13.74M | -4.63% | 130,293 | - |
| 490 | KPTI | Karyopharm Therapeutics Inc. | 13.72M | 0.83% | 962,992 | 146.62M |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 13.71M | 2.19% | 143,399 | 7.11M |
| 492 | CLRB | Cellectar Biosciences, Inc. | 13.71M | 3.57% | 91,470 | - |
| 493 | INAB | IN8bio, Inc. | 13.21M | -2.90% | 13,052 | - |
| 494 | TPST | Tempest Therapeutics, Inc. | 12.57M | -1.29% | 182,664 | - |
| 495 | GTBP | GT Biopharma, Inc. | 12.05M | 12.08% | 42,926 | - |
| 496 | PASG | Passage Bio, Inc. | 11.87M | -2.38% | 12,048 | - |
| 497 | INTS | Intensity Therapeutics, Inc. | 11.85M | -1.36% | 16,712 | - |
| 498 | DARE | Daré Bioscience, Inc. | 11.82M | 0.16% | 70,032 | 1.37M |
| 499 | PLUR | Pluri Inc. | 11.77M | -4.68% | - | 1.02M |
| 500 | NIKI | Niki BioSolutions, Inc. | 11.75M | -7.41% | 8,481 | - |